Author:
Kinzler Maximilian N.,Schulze Falko,Bankov Katrin,Gretser Steffen,Becker Nina,Leichner Regina,Stehle Angelika,Abedin Nada,Trojan Jörg,Zeuzem Stefan,Schnitzbauer Andreas A.,Wild Peter J.,Walter Dirk
Subject
Cell Biology,Pathology and Forensic Medicine
Reference19 articles.
1. Cholangiocarcinoma in Germany: epidemiologic trends and impact of misclassification;Walter;Liver Int.,2018
2. Outcomes in biliary malignancy;Groot Koerkamp;J. Surg. Oncol.,2014
3. Cisplatin plus Gemcitabine versus Gemcitabine for biliary tract cancer;Valle;N. Engl. J. Med.,2010
4. A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1;Oh;J. Clin. Oncol.,2022
5. T. Kendall, J. Verheij, E. Gaudio, et al., Anatomical, Histomorphological and Molecular Classification of Cholangiocarcinoma, Liver International. Blackwell Publishing Ltd, pp. 7–18, 01-May-2019.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献